Skip to main content
. 2010 Aug 30;3:301–309. doi: 10.2147/DMSOTT.S12375

Table 3.

Comparison of metabolic variables in control group according to the cut-off point 0.357 of the QUICKI index

Control study group
QUICKI ≥ 0.357
n = 175
QUICKI < 0.357
n = 79
Age (years) 35.6 ± 11.3 34.6 ± 11.5
BMI (kg/m2) 25.4 ± 3.7 28.8 ± 5.2*
SBP (mm Hg) 101.2 ± 11.9 103.2 ± 10.5
DBP (mm Hg) 68.1 ± 8.3 70.4 ± 7.4**
Gluc0h (mg/dL) 86.6 ± 6.5 91.3 ± 5.3*
Gluc2h (mg/dL) 99.7 ± 19.5 108.1 ± 15.7**
Ins0h (μU/mL) 4.7 ± 1.5 9.7 ± 2.8***
Ins2h (μU/mL) 33.0 ± 20.8 60.4 ± 29.9***
HOMA-IR 1.0 ± 0.3 2.2 ± 0.6***
HOMA-β 77.0 ± 36.3 132.2 ± 69.5***
TC (mg/dL) 182.9 ± 35.8 181.6 ± 34.1
HDL-C (mg/dL) 50.0 ± 12.9 42.7 ± 10.2*
TAG (mg/dL) 92.4 ± 29.7 102.8 ± 29.7*
TAG/HDL-C 2.0 ± 0.8 2.6 ± 1.0***
CVI 3.8 ± 0.9 4.4 ± 0.9*

Notes: Results are expressed as mean ± standard deviation.

*

P # 0.05, Kruskal–Wallis one-way analysis of variance;

**

P # 0.05, one-way analysis of variance;

***

P # 0.05, Mann–Whitney U test.

Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; Glc0h, fasting glucose; Gluc2h, Glucose 2 hours after a 75-g of glucose oral load; Ins0h, fasting insulin; Ins2h, insulin 2 hours after 75-g of oral glucose load; TC, total cholesterol; HDL-C, cholesterol combined with high-density lipoprotein; TAG, triacylglycerides; HOMA-IR, homeostatic model assessment of insulin resistance; HOMA-β, homeostatic model assessment of β-cell function; QUICKI, index to check the quantitative insulin sensitivity; FH-T2D, family history of type 2 diabetes mellitus; CVI, Castelli Cardiovascular Index.